You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Patent: 10,307,464


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,307,464
Title:Use of ultrarapid acting insulin
Abstract: Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Inventor(s): Boss; Anders Hasager (Princeton, NJ), Petrucci; Richard (New Canaan, CT)
Assignee: MannKind Corporation (Westlake Village, CA)
Application Number:15/300,239
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,307,464

Introduction

When analyzing a patent, particularly one like United States Patent 10,307,464, it is crucial to delve into the claims, the broader patent landscape, and the tools and strategies available for patent search and analysis. This article will provide a comprehensive and critical analysis of these aspects.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. For a patent like 10,307,464, understanding the claims involves several key steps:

Identifying Independent and Dependent Claims

Independent claims stand alone and define the invention without reference to other claims. Dependent claims, however, refer back to and further limit the independent claims. A system like the one described in US20110138338A1 can help in parsing and arranging these claims in a hierarchical order, making it easier to understand their relationships and scope[2].

Analyzing Claim Language

The language used in the claims is critical. It must be precise and clear to avoid ambiguity. For example, the case of Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd. highlights the importance of claim language and the potential limitations imposed by narrowing amendments during the patent prosecution process[2].

Conducting a Preliminary Patent Search

Before diving into the specifics of a patent, it is essential to conduct a preliminary search to understand the prior art and the broader patent landscape.

Using Patent Public Search Tools

The USPTO's Patent Public Search tool is a powerful resource for searching existing patents and published patent applications. This tool replaces legacy search tools like PubEast and PubWest and offers enhanced access to prior art[1].

Global Dossier and International Searches

For a comprehensive search, one must also consider international patent databases. The Global Dossier service provides access to file histories of related applications from participating IP Offices, allowing users to see the patent family and related applications filed globally[1].

Public Search Facilities and PTRCs

The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer additional resources, including trained staff to assist in patent search techniques[1].

Patent Landscape Analysis

Analyzing the patent landscape involves understanding the current state of patents in the relevant field and identifying key players, trends, and potential challenges.

Identifying Key Players

In the context of US Patent 10,307,464, identifying key players involves looking at other patents and patent holders in the same technological area. This can be done using tools like the Common Citation Document (CCD) which consolidates prior art cited by multiple offices for the same invention[1].

Understanding Patent Assertion Entities (PAEs)

PAEs, also known as "patent trolls," play a significant role in the patent landscape. They can be categorized into Portfolio PAEs and Litigation PAEs, each with different business models and strategies for asserting patents. Understanding these entities can help in anticipating potential litigation or licensing challenges[4].

The Role of AI in Patent Search and Analysis

AI tools are increasingly being used in patent search and analysis to streamline the process and reduce the volume of information to be reviewed.

Disclosure Requirements

When using AI tools, it is crucial to disclose any material information to the USPTO, especially if the AI system contributes significantly to the invention or the drafting of the patent application. This includes assessing whether the contributions made by natural persons rise to the level of inventorship[3].

Accuracy and Verification

Practitioners must verify the accuracy of factual assertions made by AI tools to ensure that the documents submitted do not introduce inaccurate statements or omit material information[3].

Tools and Resources for Patent Analysis

Patent Examination Data System (PEDS)

The PEDS allows public users to search, view, and download bibliographic data for all publicly available patent applications. This can be particularly useful for bulk data analysis and managing large volumes of patent data[1].

Sequence Listings and Other Mega Items

For patents involving sequences or other mega items, resources like the Publication Site for Issued and Published Sequences (PSIPS) provide access to sequence listings and tables, which can be crucial for detailed analysis[1].

Critical Analysis of US Patent 10,307,464

Claim Scope and Validity

A critical analysis of the claims in US Patent 10,307,464 would involve examining the scope and validity of each claim. This includes checking for any potential issues with claim language, ensuring that the claims are supported by the specification, and verifying that the claims do not infringe on prior art.

Prior Art and Novelty

Using tools like the Patent Public Search and Global Dossier, one can identify prior art that may affect the novelty and non-obviousness of the invention claimed in US Patent 10,307,464. Ensuring that the invention is novel and non-obvious is crucial for maintaining the validity of the patent.

Market Impact and Licensing

Understanding the market impact of the patent involves analyzing the broader patent landscape and identifying potential licensing opportunities or challenges. This includes considering the activities of PAEs and other patent holders in the same field.

Key Takeaways

  • Comprehensive Search: Conduct a thorough search using tools like Patent Public Search, Global Dossier, and international patent databases to understand the prior art and broader patent landscape.
  • Claim Analysis: Carefully analyze the claims to ensure they are clear, precise, and supported by the specification.
  • AI Tools: Use AI tools to streamline the search and analysis process but ensure to disclose any material contributions and verify the accuracy of the information.
  • PAEs and Litigation: Be aware of the activities of PAEs and their potential impact on the patent landscape.
  • Market Analysis: Analyze the market impact of the patent and identify potential licensing opportunities or challenges.

FAQs

Q: What is the importance of claim language in a patent? A: Claim language is crucial as it defines the scope of the invention and what is protected by the patent. Ambiguous or poorly drafted claims can lead to invalidation or narrowing of the patent scope.

Q: How can AI tools be used in patent search and analysis? A: AI tools can help in automating the search process, parsing claims, and reducing the volume of information to be reviewed. However, any material contributions by AI must be disclosed to the USPTO.

Q: What are Patent Assertion Entities (PAEs), and how do they impact the patent landscape? A: PAEs are entities that acquire and assert patents for revenue. They can be categorized into Portfolio PAEs and Litigation PAEs, each with different strategies that can significantly impact the patent landscape through licensing and litigation.

Q: What resources are available for conducting a comprehensive patent search? A: Resources include the USPTO's Patent Public Search tool, Global Dossier, Public Search Facilities, PTRCs, and international patent databases like those provided by the EPO, JPO, and WIPO.

Q: Why is it important to verify the accuracy of information generated by AI tools in patent applications? A: Verifying the accuracy ensures that the documents submitted do not introduce inaccurate statements or omit material information, which is crucial for maintaining the integrity and validity of the patent application.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - US20110138338A1: https://patents.google.com/patent/US20110138338A1/en
  3. BIPC - U.S. Patent Office Issues Additional Guidance on Use of AI Tools: https://www.bipc.com/united-states-patent-office-issues-guidance-on-use-of-ai-tools
  4. FTC - Patent Assertion Entity Activity: An FTC Study: https://www.ftc.gov/system/files/documents/reports/patent-assertion-entity-activity-ftc-study/p131203_patent_assertion_entity_activity_an_ftc_study_0.pdf
  5. PubChem - Process for making thixotropic detergent compositions: https://pubchem.ncbi.nlm.nih.gov/patent/US-4927555-A

More… ↓

⤷  Try for Free

Details for Patent 10,307,464

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 October 28, 1982 10,307,464 2040-04-01
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 December 29, 2015 10,307,464 2040-04-01
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 August 06, 1998 10,307,464 2040-04-01
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 March 31, 1994 10,307,464 2040-04-01
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 May 25, 2018 10,307,464 2040-04-01
Novo Nordisk Inc. NOVOLIN R insulin human Injection 019938 June 25, 1991 10,307,464 2040-04-01
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.